Directing Patients to Preferred Pharmacies
Blue Cross Blue Shield of California has proposed steering patients to preferred pharmacies through a tiered pharmacy network. Through the proposal, consumers would have to pick a preferred pharmacy and going to an out-of-network pharmacy could result in patients paying up to $50 more for the same prescription, reported Kaiser Health News. Blue Shield of California says the move will stabilize increasing costs of drugs, but patient advocates and pharmacists say the plan could confuse patients.
Opioid Crisis Opens Up New Legal Front
Lawsuits targeting drug distributors are seeking billions of dollars to pay for the effects of the opioid epidemic. Attorneys in West Virginia have filed the first lawsuits, but attorneys general in other states are considering similar actions, according to The Washington Post. The West Virginia lawsuits name McKesson Corp, Cardinal Health, AmerisourceBergen, Walgreens, CVS, and more. Cardinal Health and AmerisourceBergen recently settled lawsuits related to consumer protections with the West Virginia attorney general’s office.
Zika Linked to Heart Problems
Researchers now suspect that the Zika virus can affect the heart, too. According to The Wall Street Journal, 9 patients reported cardiac symptoms 2 weeks or less after developing signs of Zika. The cardiac symptoms varied from heart palpitations to heart failure. More research will need to be done to confirm the findings of this small study.
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More